1870 related articles for article (PubMed ID: 19108801)
1. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
2. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
Giacoia GP; Taylor-Zapata P; Zajicek A
Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
[TBL] [Abstract][Full Text] [Related]
3. European perspectives on pediatric formulations.
Breitkreutz J
Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
[TBL] [Abstract][Full Text] [Related]
4. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
Giacoia GP; Taylor-Zapata P; Mattison D
Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
[TBL] [Abstract][Full Text] [Related]
5. Extemporaneous drug formulations.
Nahata MC; Allen LV
Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
[TBL] [Abstract][Full Text] [Related]
6. Criteria supporting the study of drugs in the newborn.
Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
[TBL] [Abstract][Full Text] [Related]
7. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
8. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
Breslow LH
Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
[TBL] [Abstract][Full Text] [Related]
9. Selected Proceedings of the NICHD/FDA newborn drug development initiative: Part II.
Giacoia GP; Mattison DR
Clin Ther; 2006 Sep; 28(9):1337-41. PubMed ID: 17062307
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials in pediatrics: The drug delivery dimension.
Osuntokun B
Adv Drug Deliv Rev; 2006 Apr; 58(1):90-105. PubMed ID: 16529842
[TBL] [Abstract][Full Text] [Related]
11. Pediatric research: coming of age in the new millennium.
Milne CP
Am J Ther; 1999 Sep; 6(5):263-82. PubMed ID: 11329108
[TBL] [Abstract][Full Text] [Related]
12. Children on losing end of access to new drugs.
AIDS Alert; 1998 Jan; 13(1):10-2. PubMed ID: 11364862
[TBL] [Abstract][Full Text] [Related]
13. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
14. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
15. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
Pflieger M; Bertram D
Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
[TBL] [Abstract][Full Text] [Related]
16. Stimulation programs for pediatric drug research--do children really benefit?
Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic kits in parasitology: which controls?].
Rossi P
Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
[TBL] [Abstract][Full Text] [Related]
18. Estimates of pediatric medication use in the United States: current abilities and limitations.
Lasky T
Clin Ther; 2009 Feb; 31(2):436-45. PubMed ID: 19302916
[TBL] [Abstract][Full Text] [Related]
19. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
20. Drug development for children: how is pharma tackling an unmet need?
Hawcutt DB; Smyth RL
IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
